David S. Snyder
CFO & COOMr. David S. Snyder, MBA., has been the Chief Financial Officer and Chief Operating Officer at Coya Therapeutics, Inc. since March 2022. He has been Chief Financial Officer at DisperSol Technologies LLC (which subsequently changed its name to AustinPx Pharmaceutics and Manufacturing in 2022) since October 1, 2020. Prior to joining DisperSol, from 2014-2020 Mr. Snyder was the CFO of Exicure, Inc. (Nasdaq: XCUR) a company developing nucleic acid therapeutics. Mr. Snyder was Chief Financial Officer at Exicure Inc. (also known as AuraSense Therapeutics, LLC) since July 11, 2014 until September 30, 2020 and Served as its Secretary until September 30, 2020. Mr. Snyder had been the Chief Financial Officer and Vice President of Finance at Roche NimbleGen, Inc. since January 2006 and also served as its Principal Accounting Officer. Mr. Snyder serves as a Consultant to a number of entrepreneurial ventures. Mr. Snyder has financial and strategic experience from leadership roles at rapidly growing ventures, ranging from startups to companies traded on NASDAQ. Mr. Snyder served as the Chief Financial Officer at Cellular Dynamics International, Inc. from December 2008 to July 10, 2014, its Executive Vice President from 2008 to July 10, 2014 and served as its Principal Accounting Officer until July 10, 2014, where he was responsible for all financial functions, human resources and general administration. He helped lead CDI's successful IPO in July 2013. Mr. Snyder served as Vice President of Cellular Dynamics. Mr. Snyder served as Chief Financial Officer of CompassCare, Inc. from May 2005 to January 2006. He served as Chief Financial Officer of Viking Acquisition LLC from June 2003 to January 2005. He served as Executive Vice President and Chief Financial Officer for The Cobalt Group, Inc. from May 2000 to 2001. From September 1996 to August 1997, Mr. Snyder served as Executive Vice President, Chief Financial Officer and Chief Operating Officer of Equity Capital Holdings, LLC. He served as Chief Financial Officer for Strategic Hotel Capital, LLC. He served as Senior Vice President of Finance, site Vice President and Chief Financial Officer of Roche NimbleGen from 2007 to 2008. From 2006 to 2007, he served as Vice President and Chief Financial Officer of NimbleGen Systems, Inc. Before 2007, Mr. Snyder held various leadership positions in software, real estate and diversified manufacturing industries. From September 1997 to May 2000, he served as the Chief Financial Officer of Mark Controls, Inc. from 1992 to 1994 and Vice President of Financial and Strategic Planning for Eagle Industries, Inc., from 1988 to 1992. He had been a Director of Invenra, Inc. since 2012 until February 2025. He had been the Board of Trustees of Ottawa University since 2012 to 2014. He was engaged in non-profit and other consulting ventures from 2001 to 2003. He holds BS in economics from Ottawa University. He received a B.A., summa cum laude from Ottawa University, an MBA with high honors from the Harvard Business School and was designated a George Fisher Baker Scholar.
Positions
- Company NameCoya Therapeutics, Inc.Stock CodeCOYAPositionCFO & COOColleagues
- ASArun SwaminathanCEO & Director
- FGFred GrossmanPresident & Chief Medical Officer
- ATAaron ThomeHead of Neuroinflammation Platform
- MFMichelle FrazierSenior Vice President of Regulatory
- AVAnabella VillalobosIndependent Director
- DADov A. GoldsteinIndependent Director
- DWDieter WeinandIndependent Director
- ALAnn L. LeeIndependent Director
